4//SEC Filing
Knight Jeff E. 4
Accession 0000950170-24-079152
CIK 0001658247other
Filed
Jun 27, 8:00 PM ET
Accepted
Jun 28, 5:31 PM ET
Size
4.9 KB
Accession
0000950170-24-079152
Insider Transaction Report
Form 4
Knight Jeff E.
Chief Operating Officer
Transactions
- Sale
Common Stock
2024-06-26$44.38/sh−956$42,427→ 52,580 total
Footnotes (2)
- [F1]The sale reported in this Form 4 was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- [F2]Includes 956 shares acquired under the Issuer's Employee Stock Purchase Plan.
Documents
Issuer
Crinetics Pharmaceuticals, Inc.
CIK 0001658247
Entity typeother
Related Parties
1- filerCIK 0001881007
Filing Metadata
- Form type
- 4
- Filed
- Jun 27, 8:00 PM ET
- Accepted
- Jun 28, 5:31 PM ET
- Size
- 4.9 KB